experimental group:Integrative MTX with Guanxinning

2 trials

Sponsors

Zhejinag University of f Chinese Medicine

Conditions

Systemic lupus erythematosus

Early Phase 1

Clinical study of guanxining tablet in the treatment of rheumatoid arthritis with cardiovascular damage

RecruitingITMCTR2000003055

Zhejinag University of f Chinese MedicineSystemic lupus erythematosus

Start: 2020-03-01Updated: 2023-02-20

Clinical study of guanxining tablet in the treatment of rheumatoid arthritis with cardiovascular damage

RecruitingChiCTR2000030247

Zhejinag University of f Chinese MedicineSystemic lupus erythematosus

Start: 2020-03-01Updated: 2020-03-02

Related Papers

Protocol for rheumatoid arthritis complicated with cardiovascular damage treated with Guanxining tablet with a randomized controlled trial.

2023-08-221 citations